US2017136056A1PendingUtilityA1

Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds

54
Assignee: SYNEDGEN INCPriority: Sep 2, 2009Filed: Jan 30, 2017Published: May 18, 2017
Est. expirySep 2, 2029(~3.1 yrs left)· nominal 20-yr term from priority
A61P 31/04A61P 11/12A61P 11/00A61P 17/00A61K 31/722A61K 9/0043A61K 9/0053A61K 9/0014Y02A50/30
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Described herein are methods of disrupting (e.g., reducing the viscosity of, or dissolving) a preformed biofilm in a subject, the method comprising: administering to the subject an effective amount of a composition comprising a soluble chitosan or derivatized chitosan wherein the soluble chitosan or deritvatized chitosan when administered contacts the preformed biofilm, thereby disrupting (e.g., reducing the viscosity of, or dissolving) the preformed biofilm.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method of disrupting (e.g., reducing the viscosity of, or dissolving) a preformed biofilm in a subject, the method comprising:
 administering to the subject an effective amount of a composition comprising a soluble derivatized chitosan wherein the soluble derivatized chitosan when administered contacts the preformed biofilm, thereby disrupting (e.g., reducing the viscosity of, or dissolving) the preformed biofilm;   
       wherein the derivatized chitosan comprises a chitosan of the following formula (I): 
       
         
           
           
               
               
           
         
         wherein: 
         n is an integer between 20 and 6000; and 
         each R 1  is independently selected for each occurrence from hydrogen, acetyl, and a group of formula (II): 
       
       
         
           
           
               
               
           
         
         or R 1 , when taken together with the nitrogen to which it is attached, forms a guanidine moiety, 
         wherein R 2  is hydrogen or amino; and 
         R 3  is amino, guanidino, C 1 -C 6  alkyl substituted with an amino or guanidino moiety, or a natural or unnatural amino acid side chain, 
         wherein at least 25% of R 1  substituents are H, at least 1% of R 1  substituents are acetyl, and at least 2% of R 1  substituents are a group of formula (II).

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.